Filter
Period
Filter by
recent search
Showing: 1 – 05 of 152 Regulated Information
–
09 August 2022
09 August 2022
LinkedIn
Facebook
Share buyback program – Ipsen reporting from 01 to 05 August 2022 – Detailed
This article or press release has no online content. Please download the associated documents for more information.
–
05 August 2022
05 August 2022
LinkedIn
Ipsen extends expiration date of tender offer for Epizyme, Inc. to 11 August 2022
PARIS, FRANCE, 5 August 2022 – Ipsen S.A. (Euronext: IPN; ADR: IPSEY) today announced that Hibernia Merger Sub, Inc. (Purchaser), its wholly owned indirect subsidiary, has extended the expiration time for the previously announced tender offer to purchase all of the…
–
02 August 2022
02 August 2022
LinkedIn
Share buyback program – Ipsen reporting from 25 July to 29 July 2022 – Detailed
This article or press release has no online content. Please download the associated documents for more information.
–
28 July 2022
28 July 2022
LinkedIn
Ipsen delivers strong H1 2022 results and upgrades its full-year guidance
Paris (France), 28 July 2022 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, presents its financial results for the first half of 2022:
–
28 July 2022
28 July 2022
LinkedIn
Ipsen publishes its 2022 half year financial report
This article or press release has no online content. Please download the associated documents for more information.